Norwegian Spontaneous Coronary Artery Dissection Study

The Norwegian Spontaneous Coronary Artery Dissection Study (NOR-SCAD) is a national, multicenter prospective observational study conducted at major hospitals in Norway. The study investigates risk factors and complications of spontaneous coronary artery dissection (SCAD). Patients aged 18 years or older who are hospitalized with SCAD are recruited during the index hospitalization. Each participant will be followed for 52 weeks with scheduled visits at 8 and 12 weeks and a final phone call at 52 weeks. Evaluations include coronary CT angiography (CTA), cardiac assessments, genetic analyses, blood sampling, structured questionnaires, and a cardiopulmonary exercise test (CPET).

NCT Number	NCT07317323
Lead Sponsor	Oslo University Hospital Collaborators: University Hospital, Akershus, Haukeland University Hospital, Bergen, Norway, Sorlandet Hospital HF, Universitetssykehuset i Nord-Norge HF, Ullevaal University Hospital, Helse Stavanger HF, St. Olavs Hospital
Conditions	SCAD, Myocardial Infarction (MI), Women
Enrollment	300 participants
Start Date	2025-04-01
Primary Completion	2035-12-31 (estimated)
Study Completion	2035-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-05